- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 471/12 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups in which the condensed system contains three hetero rings
Patent holdings for IPC class C07D 471/12
Total number of patents in this class: 178
10-year publication summary
19
|
19
|
8
|
5
|
10
|
9
|
17
|
11
|
10
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Janssen Pharmaceutica N.V. | 3610 |
11 |
Merck Patent GmbH | 5864 |
5 |
Senhwa Biosciences, Inc. | 43 |
5 |
LG Chem, Ltd. | 17662 |
4 |
ChemoCentryx, Inc. | 392 |
4 |
Bristol-myers Squibb Company | 4864 |
3 |
BASF SE | 20501 |
3 |
Syngenta Participations AG | 3029 |
3 |
Takeda Pharmaceutical Company Limited | 2946 |
3 |
Intra-Cellular Therapies, Inc. | 393 |
3 |
Oncoceutics, Inc. | 30 |
3 |
Owens Corning Intellectual Capital, LLC | 1565 |
3 |
Tel Hashomer Medical Research Infrastructure and Services Ltd. | 334 |
3 |
Neuron23, Inc. | 22 |
3 |
Novartis AG | 11234 |
2 |
Coley Pharmaceutical Group, Inc. | 52 |
2 |
Abbvie Inc. | 1786 |
2 |
BeiGene, Ltd. | 353 |
2 |
Deciphera Pharmaceuticals, LLC | 201 |
2 |
Eli Lilly and Company | 3734 |
2 |
Other owners | 110 |